Rivaroxaban D4
| Product Name | Rivaroxaban D4 |
|---|---|
| Alternate Names | Rivaroxaban Stable Isotopes, Stable Isotopes of Rivaroxaban |
| CAT No. | CS-O-10103 |
| CAS No. | 1132681-38-9 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 439.91 g/mol |
| Mol. For. | C₁₉H₁₄D₄ClN₃O₅S |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Rivaroxaban |
| Purity | 95% |
| Therapeutic | Anti-Thrombotics |
| Smileys | O=C1N(C(C([2H])=C2[2H])=C(C([2H])=C2N(CCOC3)C3=O)[2H])C[C@H](CNC(C4=CC=C(Cl)S4)=O)O1 |
| Canonical Smiles | C1COCC(=O)N1C2=CC=C(C=C2)N3CC(OC3=O)CNC(=O)C4=CC=C(S4)Cl |
| InchIKey | KGFYHTZWPPHNLQ-UJCPGTITSA-N |
| Inchl | InChI=1S/C19H18ClN3O5S/c20-16-6-5-15(29-16)18(25)21-9-14-10-23(19(26)28-14)13-3-1-12(2-4-13)22-7-8-27-11-17(22)24/h1-6,14H,7-11H2,(H,21,25)/t14-/m0/s1/i1D,2D,3D,4D |
| IUPAC | 5-chloro-N-[[(5S)-2-oxo-3-[2,3,5,6-tetradeuterio-4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]thiophene-2-carboxamide |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Rivaroxaban D4 is a deuterated form of the anticoagulant medication, Rivaroxaban. It is used for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation, deep vein thrombosis, and pulmonary embolism. This medication works by inhibiting the activity of Factor Xa, which is a key component in the blood clotting process. By doing so, Rivaroxaban D4 effectively prevents the formation of blood clots and reduces the risk of serious medical events such as stroke or pulmonary embolism.
Chemically, Rivaroxaban D4 is a white to yellowish crystalline powder with a molecular formula of C19H18D4ClN3O4S. It has a molecular weight of 432.98 g/mol and is soluble in organic solvents such as DMSO and methanol. The deuterated form of Rivaroxaban has been developed to aid in the quantification and analysis of the drug in biological samples.
Rivaroxaban D4 is typically administered orally in tablet form, and the dosage varies based on the medical condition being treated. It is important to follow the dosing instructions provided by the healthcare provider to ensure effective treatment and minimize the risk of side effects.
In conclusion, Rivaroxaban D4 is an important medication used to prevent serious medical events related to blood clots. Its chemical properties allow for accurate analysis and quantification in biological samples, ensuring proper dosing and effective treatment.
Get an Instant Quote
Related Compounds
Rac-N-Nitroso Rivaroxaban Phthalimido Analog D4 | Rivaroxaban 13C6 | N-Nitroso Rivaroxaban Open-Ring Acid D4 | Rivaroxaban nitrosamine impurity II D4 | N-Nitroso Rivaroxaban Phthalimido Analog D4 |